Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ischemic Heart Disease

  Free Subscription


Articles published in Thromb Haemost

Retrieve available abstracts of 64 articles:
HTML format



Single Articles


    October 2024
  1. VAN DER SANGEN NMR, Azzahhafi J, Chan Pin Yin DRPP, Zaaijer LJG, et al
    Treatment Modifications in Acute Coronary Syndrome Patients Treated with Ticagrelor: Insights from the FORCE-ACS Registry.
    Thromb Haemost. 2024 Oct 29. doi: 10.1055/a-2421-8866.
    PubMed     Abstract available


  2. GRAGNANO F, Angiolillo D
    Ticagrelor therapy modifications after acute coronary syndrome: An ever-evolving issue.
    Thromb Haemost. 2024 Oct 24. doi: 10.1055/a-2448-7029.
    PubMed     Abstract available


  3. ASARE Y, Simsekyilmaz S, Kohncke J, Shagdarsuren G, et al
    Cardiac repair after myocardial infarction is controlled by a complement C5a receptor 1-driven signaling cascade.
    Thromb Haemost. 2024 Oct 4. doi: 10.1055/a-2434-4905.
    PubMed     Abstract available


    September 2024
  4. GEISLER T
    Editorial : "Clinical impact of dyspnea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction".
    Thromb Haemost. 2024 Sep 23. doi: 10.1055/a-2420-0381.
    PubMed     Abstract available


    August 2024
  5. KONSTANTINIDES SV
    Shifting Priorities in the Prevention of Venous Thromboembolism: Time to Focus on Overall Cardiovascular Health.
    Thromb Haemost. 2024 Aug 12. doi: 10.1055/s-0044-1788926.
    PubMed    


    June 2024
  6. HRISTOV M, Weber C
    Monocyte subsets in cardiovascular disease: a biomarker perspective.
    Thromb Haemost. 2024 Jun 19. doi: 10.1055/a-2348-5697.
    PubMed     Abstract available


  7. CATTANEO M, Squizzato A, Birocchi S, Podda GM, et al
    Guided Anti-P2Y12 Therapy in Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2024;124:595-597.
    PubMed    


  8. UEKI Y, Haner JD, Losdat S, Gargiulo G, et al
    Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial.
    Thromb Haemost. 2024;124:517-527.
    PubMed     Abstract available


    May 2024
  9. BIROCCHI S, Rocchetti M, Minardi A, Podda GM, et al
    Guided Anti-P2Y12 Therapy in Patients Undergoing PCI: Three Systematic Reviews with Meta-analyses of Randomized Controlled Trials with Homogeneous Design.
    Thromb Haemost. 2024;124:482-496.
    PubMed     Abstract available


    April 2024
  10. LIANG B, Zha L, Peng B, Chen Q, et al
    Association of Cardiovascular Health with the Incidence of Venous Thromboembolism: A Prospective Study of 275,149 Participants from the UK Biobank.
    Thromb Haemost. 2024 Apr 12. doi: 10.1055/a-2305-6631.
    PubMed     Abstract available


  11. KIM SH, Shin S, Choo EH, Choi IJ, et al
    Clinical impact of dyspnoea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction.
    Thromb Haemost. 2024 Apr 4. doi: 10.1055/a-2299-4537.
    PubMed     Abstract available


    March 2024
  12. ORTEGA-PAZ L, Franchi F, Rollini F, Galli M, et al
    Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
    Thromb Haemost. 2024;124:263-273.
    PubMed     Abstract available


    December 2023
  13. SUH JW, Memtsas V, Gue YX, Cho HW, et al
    Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects.
    Thromb Haemost. 2023 Dec 29. doi: 10.1055/s-0043-1777794.
    PubMed     Abstract available


  14. LI J, Chen R, Zhou J, Wang Y, et al
    Atherosclerotic Autoantigen ALDH4A1 as a Novel Immunological Indicator for Plaque Erosion in Patients with ST Segment Elevated Myocardial Infarction.
    Thromb Haemost. 2023 Dec 18. doi: 10.1055/s-0043-1777265.
    PubMed     Abstract available


  15. YE Y, Hao Y, Zhao X, Liu J, et al
    Percutaneous coronary intervention in acute coronary syndrome with mild-to-moderate thrombocytopenia.
    Thromb Haemost. 2023 Dec 11. doi: 10.1055/a-2225-5263.
    PubMed     Abstract available


    October 2023
  16. PEDERSEN OB, Hvas AM, Pasalic L, Kristensen SD, et al
    Platelet Function and Maturity and Related microRNA Expression in Whole Blood in Patients with ST-Segment Elevation Myocardial Infarction.
    Thromb Haemost. 2023 Oct 16. doi: 10.1055/s-0043-1776305.
    PubMed     Abstract available


    September 2023
  17. BONGIOVANNI D, Novelli L, Condello F, Kirmes K, et al
    Reticulated Platelets Predict Cardiovascular Death and Adverse Events in Coronary Artery Disease: A Systematic Review and Meta-analysis.
    Thromb Haemost. 2023 Sep 11. doi: 10.1055/s-0043-1773763.
    PubMed     Abstract available


  18. ESTEVE-PASTOR MA, Soler E, Marin F
    Reticulated platelets: a promising prognosis marker in cardiovascular diseases.
    Thromb Haemost. 2023 Sep 7. doi: 10.1055/a-2170-1892.
    PubMed     Abstract available


  19. VILELLA-FIGUEROLA A, Cordero A, Mirabet S, Munoz-Garcia N, et al
    Platelet-Released Extracellular Vesicle Characteristics Differ in Chronic and in Acute Heart Disease.
    Thromb Haemost. 2023;123:892-903.
    PubMed     Abstract available


    August 2023
  20. HE HM, Chen YN, Zeng JL, Zheng SW, et al
    The Prognostic Value of the Age-D-Dimer-Albumin Score in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2023 Aug 29. doi: 10.1055/s-0043-1773764.
    PubMed     Abstract available


  21. LAHU S, Adler K, Mayer K, Hein-Rothweiler R, et al
    Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention.
    Thromb Haemost. 2023 Aug 17. doi: 10.1055/s-0043-1772221.
    PubMed     Abstract available


  22. GOROG DA, Jeyalan V, Markides RIL, Navarese EP, et al
    Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with ACS Undergoing PCI: A Systematic Review and Meta-analysis.
    Thromb Haemost. 2023;123:773-792.
    PubMed     Abstract available


    July 2023
  23. WANG P, Yuan D, Zhao X, Zhu P, et al
    Inverse Association of Lipoprotein(a) on Long-Term Bleeding Risk in Patients with Coronary Heart Disease: Insight from a Multicenter Cohort in Asia.
    Thromb Haemost. 2023 Jul 24. doi: 10.1055/s-0043-1771188.
    PubMed     Abstract available


    June 2023
  24. HARM T, Frey M, Dittrich K, Goldschmied A, et al
    Statin Treatment Is Associated with Alterations in the Platelet Lipidome.
    Thromb Haemost. 2023;123:585-596.
    PubMed     Abstract available


  25. SONG H, Ahn JH, Kang MG, Kim KH, et al
    Post-PCI Risk Assessment by Inflammation Activity According to Disease Acuity and Time from Procedure.
    Thromb Haemost. 2023;123:627-640.
    PubMed     Abstract available


    May 2023
  26. GIANNIS D, Goldin M, Rahman H, Sison CP, et al
    Risk factors for post-discharge major thromboembolism and mortality in hospitalized patients with COVID-19 with cardiovascular comorbidities.
    Thromb Haemost. 2023 May 5. doi: 10.1055/a-2087-3003.
    PubMed     Abstract available


    April 2023
  27. CHEN D, Zhao Z, Liu P, Liu X, et al
    Adventitial Vasa Vasorum Neovascularization in Femoral Artery of Type 2 Diabetic Patients with Macroangiopathy Is Associated with Macrophages and Lymphocytes as well as the Occurrence of Cardiovascular Events.
    Thromb Haemost. 2023 Apr 10. doi: 10.1055/s-0043-1768162.
    PubMed     Abstract available


    March 2023
  28. LIU D, Zhang P, Zhang K, Bi C, et al
    Role of GPR56 in Platelet Activation and Arterial Thrombosis.
    Thromb Haemost. 2023;123:295-306.
    PubMed     Abstract available


    January 2023
  29. NICOLAJSEN CWW, Bronnum Nielsen P, Jensen M, Eldrup N, et al
    Stroke and myocardial infarction in patients with abdominal aortic aneurysms and new-onset atrial fibrillation.
    Thromb Haemost. 2023 Jan 10. doi: 10.1055/a-2009-8954.
    PubMed     Abstract available


  30. VERHEUGT FWA, Huber K
    Continuous Improvement of Antiplatelet Therapy in Cardiovascular Disease.
    Thromb Haemost. 2023 Jan 5. doi: 10.1055/s-0042-1760129.
    PubMed    


  31. PEDERSEN OB, Grove EL, Nissen PH, Larsen SB, et al
    Expression of microRNA Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease.
    Thromb Haemost. 2023 Jan 5. doi: 10.1055/s-0042-1760258.
    PubMed     Abstract available


  32. ZHU W, Cao Y, Ye M, Huang H, et al
    Essen Stroke Risk Score Predicts Clinical Outcomes in Heart Failure Patients with Preserved Ejection Fraction: Evidence from the TOPCAT trial.
    Thromb Haemost. 2023;123:85-96.
    PubMed     Abstract available


    December 2022
  33. NILSEN DWT, Roysland M, Ueland T, Aukrust P, et al
    The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease.
    Thromb Haemost. 2022 Dec 31. doi: 10.1055/s-0042-1760256.
    PubMed     Abstract available


  34. VERHEUGT FWA, Huber K, Clemmensen P, Collet JP, et al
    Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation.
    Thromb Haemost. 2022 Dec 30. doi: 10.1055/s-0042-1755330.
    PubMed     Abstract available


    November 2022
  35. KOCH T, Lahu S, Coughlan JJ, Cassese S, et al
    Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
    Thromb Haemost. 2022 Nov 28. doi: 10.1055/a-1988-5047.
    PubMed     Abstract available


  36. SHAO QY, Wang ZJ, Ma XT, Wang YF, et al
    Mortality of Escalation and Modulation Antithrombotic Therapy in Coronary Artery Disease Patients: A Meta-analysis of Randomized Controlled Trials.
    Thromb Haemost. 2022 Nov 7. doi: 10.1055/s-0042-1757405.
    PubMed     Abstract available


    October 2022
  37. BUCKLEY BJR, Lip GYH
    Current Concepts: Comprehensive "Cardiovascular Health" Rehabilitation-An Integrated Approach to Improve Secondary Prevention and Rehabilitation of Cardiovascular Diseases.
    Thromb Haemost. 2022 Oct 28. doi: 10.1055/s-0042-1757403.
    PubMed    


  38. ROONGSANGMANOON W, Chichareon P, Angkananard T, Suwannasom P, et al
    External validation of ACUITY/HORIZON bleeding risk score among acute coronary syndrome patients in Thai PCI Registry.
    Thromb Haemost. 2022 Oct 20. doi: 10.1055/a-1964-8247.
    PubMed     Abstract available


    September 2022
  39. GUEANT JL, Gueant-Rodriguez RM, Oussalah A, Zuily S, et al
    Hyperhomocysteinemia in cardiovascular diseases: revisiting observational studies and clinical trials.
    Thromb Haemost. 2022 Sep 28. doi: 10.1055/a-1952-1946.
    PubMed     Abstract available


  40. RIKKEN SAOF, Storey RF, Andreotti F, Clemmensen P, et al
    Parenteral Antiplatelet Drugs in ST-Elevation Myocardial Infarction: Current Status and Future Directions.
    Thromb Haemost. 2022 Sep 8. doi: 10.1055/s-0042-1753479.
    PubMed     Abstract available


    August 2022
  41. BAMPATSIAS D, Mavroeidis I, Tual-Chalot S, Vlachogiannis NL, et al
    Beta-secretase-1 antisense RNA is associated with vascular ageing and atherosclerotic cardiovascular disease.
    Thromb Haemost. 2022 Aug 1. doi: 10.1055/a-1914-2094.
    PubMed     Abstract available


    June 2022
  42. NOUMEGNI SR, Mansourati V, Tromeur C, Mao RL, et al
    Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study.
    Thromb Haemost. 2022 Jun 18. doi: 10.1055/s-0042-1748889.
    PubMed     Abstract available


  43. ARASHI H, Yamaguchi J, Hagiwara N, Yasuda S, et al
    Rivaroxaban Underdose for Atrial Fibrillation with Stable Coronary Disease: The AFIRE Trial Findings.
    Thromb Haemost. 2022 Jun 13. doi: 10.1055/s-0042-1744543.
    PubMed     Abstract available


  44. AKYEA RK, Georgiopoulos G, Iyen B, Kai J, et al
    Comparison of risk of serious cardiovascular events after haemorrhagic versus ischaemic stroke: a population-based study.
    Thromb Haemost. 2022 Jun 10. doi: 10.1055/a-1873-9092.
    PubMed     Abstract available


    May 2022
  45. TASOUDIS P, Kyriakoulis I, Sagris D, Diener HC, et al
    Clopidogrel monotherapy versus Aspirin monotherapy in patients with established cardiovascular disease: systematic review and meta-analysis.
    Thromb Haemost. 2022 May 16. doi: 10.1055/a-1853-2952.
    PubMed     Abstract available


  46. ZHANG Y, Zhang Y, Shi X, Lin B, et al
    Clopidogrel versus Ticagrelor in CYP2C19 Loss-of-Function Allele Noncarriers: A Real-World Study in China.
    Thromb Haemost. 2022;122:842-852.
    PubMed     Abstract available


    April 2022
  47. PATTI G, Grisafi L, Spinoni E, Rognoni A, et al
    Safety and efficacy of selective, clopidogrel-based strategies in acute coronary syndrome: a study-level meta-analysis.
    Thromb Haemost. 2022 Apr 18. doi: 10.1055/a-1827-8041.
    PubMed     Abstract available


    March 2022
  48. DEL BIANCO-RONDEAU M, Robert-Halabi M, Bloom S, Rabasa-Lhoret R, et al
    Aspirin for Primary Cardiovascular Prevention in Patients with Diabetes: Uncertainties and Opportunities.
    Thromb Haemost. 2022 Mar 4. doi: 10.1055/s-0042-1743469.
    PubMed     Abstract available


  49. MALY M, Riedel T, Stikarova J, Suttnar J, et al
    Incorporation of Fibrin, Platelets, and Red Blood Cells into a Coronary Thrombus in Time and Space.
    Thromb Haemost. 2022;122:434-444.
    PubMed     Abstract available


    February 2022
  50. LOPEZ-GALVEZ R, Rivera-Caravaca JM
    Growth differentiation factor 15 (GDF-15) in cardiovascular diseases: predicting bleeding after cardiac surgery and beyond that!
    Thromb Haemost. 2022 Feb 10. doi: 10.1055/a-1768-4206.
    PubMed     Abstract available


  51. NAVARESE EP, Grisafi L, Spinoni EG, Mennuni MG, et al
    Safety and Efficacy of Different Antithrombotic Strategies after Transcatheter Aortic Valve Implantation: A Network Meta-Analysis.
    Thromb Haemost. 2022;122:216-225.
    PubMed     Abstract available


    January 2022
  52. CLELAND JGF
    Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
    Thromb Haemost. 2022 Jan 20. doi: 10.1055/s-0041-1740639.
    PubMed    


  53. CANTONI S, Colombo C, Soriano F, Oreglia JA, et al
    RARE CAUSES OF ACUTE CORONARY SYNDROME: THE JAK2 V617F MUTATION POSITIVE MYELOPROLIFERATIVE NEOPLASMS. A cardio-hematological perspective.
    Thromb Haemost. 2022 Jan 17. doi: 10.1055/a-1742-0361.
    PubMed     Abstract available


  54. GOROG DA, Massberg S
    NETs in the infarct-related coronary artery - a marker or mediator of adverse outcome?
    Thromb Haemost. 2022 Jan 10. doi: 10.1055/a-1733-9217.
    PubMed     Abstract available


  55. CHAO TF, Joung B, Takahashi Y, Lim TW, et al
    2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.
    Thromb Haemost. 2022;122:20-47.
    PubMed     Abstract available


    November 2021
  56. BLASCO A, Coronado MJ, Vela P, Martin P, et al
    Prognostic implications of Neutrophil Extracellular Traps in coronary thrombi of patients with ST-elevation myocardial infarction.
    Thromb Haemost. 2021 Nov 30. doi: 10.1055/a-1709-5271.
    PubMed     Abstract available


    October 2021
  57. BOJIC M, Bielesz B, Cejka D, Schernthaner GH, et al
    Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery Disease.
    Thromb Haemost. 2021 Oct 31. doi: 10.1055/s-0041-1736444.
    PubMed     Abstract available


  58. MCCUTCHEON K, Manga P
    Human Immunodeficiency Virus and Cardiovascular Disease: Revisiting the Inflammation-Thrombosis Axis.
    Thromb Haemost. 2021 Oct 24. doi: 10.1055/s-0041-1736445.
    PubMed    


  59. CALDERONE D, Greco A, Ingala S, Agnello F, et al
    Efficacy and safety of aspirin for cardiovascular risk prevention in younger and older age: an updated systematic review and meta-analysis.
    Thromb Haemost. 2021 Oct 12. doi: 10.1055/a-1667-7427.
    PubMed     Abstract available


  60. JEONG YH, Oh JH, Yoon HJ, Park Y, et al
    Pharmacodynamic Profile and Prevalence of Bleeding Episode in East Asian Patients with Acute Coronary Syndromes Treated with Prasugrel Standard-Dose versus De-escalation Strategy: A Randomized A-MATCH Trial.
    Thromb Haemost. 2021;121:1376-1386.
    PubMed     Abstract available


    July 2021
  61. VERA A, Rivero F, Salamanca J, Alvarado-Casas T, et al
    Coronary Plaque Erosion after Abemaciclib Treatment Onset: An Unknown Side Effect?
    Thromb Haemost. 2021;121:976-978.
    PubMed     Abstract available


    February 2021
  62. YAMASHITA A, Nishihira K, Gi T, Maekawa K, et al
    Pathological Features of Ruptured Coronary Plaque and Thrombus Interfaces: Fibrin and von Willebrand Factor as Platelet Scaffolds on Rupture Sites.
    Thromb Haemost. 2021;121:234-241.
    PubMed     Abstract available


  63. VAN PARIDON PCS, Panova-Noeva M, van Oerle R, Schulz A, et al
    Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample.
    Thromb Haemost. 2021;121:174-181.
    PubMed     Abstract available


    January 2021
  64. MANDROLA JM, Kaul S, Foy A
    Lessons Learnt from Recent Trials in Ischemic Heart Disease.
    Thromb Haemost. 2021;121:8-14.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.